• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Ortoma

7.84 SEK

-1.38 %

Less than 1K followers

ORT B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.38 %
-6.56 %
-1.18 %
-40.92 %
-45.51 %
-40.92 %
+2.60 %
-60.17 %
+163.54 %

Ortoma operates in the medical technology sector. The company develops surgical systems for implant treatment. The technology is based on 3D models and is mainly used to plan and position implants such as hip, knee and back surgery. The products are used by orthopaedic surgeons and in various surgeries, and the business is based on research and development within the field. The company has its headquarters in Gothenburg.

Read more
Market cap
366.8M SEK
Turnover
269.73K SEK
Revenue
64.64M
EBIT %
-30.19 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
30/7
2026

Interim report Q2'26

5/11
2026

Interim report Q3'26

25/2
2027

Annual report '26

Regulatory press release5/21/2026, 2:45 PM

Kommuniké från årsstämma i Ortoma AB

Ortoma
Regulatory press release5/21/2026, 5:30 AM

Ortoma AB publicerar delårsrapport för det första kvartalet 2026

Ortoma
Regulatory press release4/22/2026, 12:30 PM

Ortoma AB publicerar årsredovisning 2025

Ortoma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/17/2026, 12:18 PM

Kallelse till årsstämma i Ortoma AB

Ortoma
Regulatory press release4/17/2026, 11:52 AM

Valberedningens förslag till årsstämman 2026

Ortoma
Regulatory press release4/16/2026, 5:09 PM

Ortomas företrädesemission övertecknad

Ortoma
Regulatory press release4/16/2026, 5:09 PM

Ortoma’s rights issue oversubscribed

Ortoma
Regulatory press release4/7/2026, 4:09 PM

Ortoma meddelar om tillkommande avsiktsförklaringar om cirka 3 MSEK från styrelse och ledning i den pågående företrädesemissionen

Ortoma
Press release3/31/2026, 9:00 AM

DNB Carnegie Access: Ortoma - Q&A + Produktdemonstration

Ortoma
Press release3/31/2026, 6:00 AM

Idag inleds teckningsperioden i Ortomas företrädesemission

Ortoma
Press release3/31/2026, 6:00 AM

The subscription period in Ortoma’s rights issue begins today

Ortoma
Regulatory press release3/30/2026, 7:01 AM

Ortoma erhåller regulatorisk registrering i Storbritannien för OTS™ Hip och erhåller milstolpsersättning om 0,5 MUSD

Ortoma
Regulatory press release3/27/2026, 9:08 AM

Ortoma offentliggör informationsdokument inför företrädesemissionen

Ortoma
Regulatory press release3/27/2026, 9:08 AM

Ortoma publishes information document regarding the rights issue

Ortoma
Press release3/25/2026, 10:38 AM

Ortoma bjuder in till livesänd Q&A tisdagen den 31 mars 2026

Ortoma
Regulatory press release3/24/2026, 3:59 PM

Kommuniké från extra bolagsstämma i Ortoma AB

Ortoma
Intervju med Ortomas VD under SCF:s 17:e Kapitalmarknadsdag Life Science7:22
Video3/19/2026, 7:07 AM by
Pia Maljanen

Intervju med Ortomas VD under SCF:s 17:e Kapitalmarknadsdag Life Science

Ortoma presenterade vid Stockholm Corporate Finance 17:e kapitalmarknadsdagar Life Science 2026.

Ortoma
Ortoma, Investor Day, Stockholm Corporate Finance Life Science Seminarium 2026
Webcast3/18/2026, 9:00 AM

Ortoma, Investor Day, Stockholm Corporate Finance Life Science Seminarium 2026

Ortoma
Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 18:e mars
Webcast3/18/2026, 7:00 AM

Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 18:e mars

Välkommen att lyssna på Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 18:e mars.

Miris HoldingDevyser DiagnosticsOrtomaNextCell PharmaSaniona
Press release3/3/2026, 8:50 AM

DNB Carnegie Access: Ortoma: Withdrawing fair value

Ortoma